Malignant Ascites – Optional Management using Hyperthermic Peroperative Chemotherapy (HIPEC)

Abstract

Conclusions: HIPEC with/without debulking is an efficient method for controlling, managing or preventing the development of malignant ascites, it extends the mean survival time of the patients (especially when bulking is feasible) with low morbidity and lethality rates of the procedure.

Keywords

• ascites
• malignant ascites
• hyperthermic intraperitoneal peroperative chemotherapy (HIPEC)